Developed by Alira Health
Integra Example Study Landing Page
Powered by
Information About this Study
This is a phase 2 randomized, open-label, active-controlled study evaluating the safety and efficacy of a new Product.
The primary objective of this study is to evaluate the efficacy of a new Product in patients currently diagnosed with this disease.
Who Can Participate
-
18 years and older
Diagnosed with this disease.
No allergy to [example medication.]
-
History of prior failure while receiving treatment for this disease.
Why Should I Participate in this Study?
This disease continues to be a serious global health issue and can be life-threatening if left untreated. Currently, there are around 17 million people around the world that are diagnosed with this disease each year.
By participating in this study, you will be doing your part in helping develop new treatments for those people.
About the Study App
This study is being conducted using the Health Storylines™ app which can be accessed through your smartphone, mobile device, laptop, personal computer, tablet, or web browser.
How to Participate
To register your interest in participating, please download the Health Storylines™ app using the links underneath to sign up for this study.
You can also scan the following QR code to access the mobile version.
Thank you for your consideration of this important research study.